Annual D&A
$695.00 K
-$265.00 K-27.60%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual depreciation & amortization is $695.00 thousand, with the most recent change of -$265.00 thousand (-27.60%) on December 31, 2022.
- During the last 3 years, ELOX annual D&A has risen by +$136.00 thousand (+24.33%).
- ELOX annual D&A is now -27.60% below its all-time high of $960.00 thousand, reached on December 31, 2021.
Performance
ELOX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$188.00 K
+$3000.00+1.62%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly depreciation & amortization is $188.00 thousand, with the most recent change of +$3000.00 (+1.62%) on September 30, 2023.
- Over the past year, ELOX quarterly D&A has dropped by -$1000.00 (-0.53%).
- ELOX quarterly D&A is now -71.16% below its all-time high of $651.80 thousand, reached on March 31, 2008.
Performance
ELOX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$737.00 K
-$1000.00-0.14%
September 30, 2023
Summary
- As of February 8, 2025, ELOX TTM depreciation & amortization is $737.00 thousand, with the most recent change of -$1000.00 (-0.14%) on September 30, 2023.
- Over the past year, ELOX TTM D&A has increased by +$18.00 thousand (+2.50%).
- ELOX TTM D&A is now -29.37% below its all-time high of $1.04 million, reached on March 31, 2008.
Performance
ELOX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ELOX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -27.6% | -0.5% | +2.5% |
3 y3 years | +24.3% | +31.5% | +30.2% |
5 y5 years | +1682.0% | +97.9% | +31.8% |
ELOX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -27.6% | at low | -6.9% | +44.6% | -27.0% | +7.9% |
5 y | 5-year | -27.6% | +24.3% | -43.2% | +55.4% | -27.0% | +38.3% |
alltime | all time | -27.6% | >+9999.0% | -71.2% | +121.0% | -29.4% | +190.3% |
Eloxx Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | $188.00 K(+1.6%) | $737.00 K(-0.1%) |
Jun 2023 | - | $185.00 K(-0.5%) | $738.00 K(+8.1%) |
Mar 2023 | - | $186.00 K(+4.5%) | $683.00 K(-1.7%) |
Dec 2022 | $695.00 K(-27.6%) | $178.00 K(-5.8%) | $695.00 K(-3.3%) |
Sep 2022 | - | $189.00 K(+45.4%) | $719.00 K(-11.1%) |
Jun 2022 | - | $130.00 K(-34.3%) | $809.00 K(-19.9%) |
Mar 2022 | - | $198.00 K(-2.0%) | $1.01 M(+5.2%) |
Dec 2021 | $960.00 K(+68.1%) | $202.00 K(-27.6%) | $960.00 K(+6.2%) |
Sep 2021 | - | $279.00 K(-15.7%) | $904.00 K(+17.7%) |
Jun 2021 | - | $331.00 K(+123.6%) | $768.00 K(+28.4%) |
Mar 2021 | - | $148.00 K(+1.4%) | $598.00 K(+4.7%) |
Dec 2020 | $571.00 K(+2.1%) | $146.00 K(+2.1%) | $571.00 K(+0.9%) |
Sep 2020 | - | $143.00 K(-11.2%) | $566.00 K(+1.1%) |
Jun 2020 | - | $161.00 K(+33.1%) | $560.00 K(+5.1%) |
Mar 2020 | - | $121.00 K(-14.2%) | $533.00 K(-4.7%) |
Dec 2019 | $559.00 K(+158.8%) | $141.00 K(+2.9%) | $559.00 K(+9.0%) |
Sep 2019 | - | $137.00 K(+2.2%) | $513.00 K(+13.7%) |
Jun 2019 | - | $134.00 K(-8.8%) | $451.00 K(+31.9%) |
Mar 2019 | - | $147.00 K(+54.7%) | $342.00 K(+58.3%) |
Dec 2018 | $216.00 K(+453.8%) | $95.00 K(+26.7%) | $216.00 K(+78.5%) |
Sep 2018 | - | $75.00 K(+200.0%) | $121.00 K(+123.2%) |
Jun 2018 | - | $25.00 K(+19.0%) | $54.20 K(+41.1%) |
Mar 2018 | - | $21.00 K(+156.1%) | $38.40 K(-5.7%) |
Dec 2017 | $39.00 K(-11.6%) | - | - |
Sep 2017 | - | $8200.00(-10.9%) | $40.70 K(-7.7%) |
Jun 2017 | - | $9200.00(-2.1%) | $44.10 K(-7.5%) |
Jun 2017 | $44.10 K(-52.8%) | - | - |
Mar 2017 | - | $9400.00(-32.4%) | $47.70 K(-16.6%) |
Dec 2016 | - | $13.90 K(+19.8%) | $57.20 K(-21.5%) |
Sep 2016 | - | $11.60 K(-9.4%) | $72.90 K(-21.9%) |
Jun 2016 | $93.40 K(-47.3%) | $12.80 K(-32.3%) | $93.40 K(-21.3%) |
Mar 2016 | - | $18.90 K(-36.1%) | $118.70 K(-14.3%) |
Dec 2015 | - | $29.60 K(-7.8%) | $138.50 K(-7.0%) |
Sep 2015 | - | $32.10 K(-15.7%) | $149.00 K(-15.8%) |
Jun 2015 | $177.10 K(-49.4%) | $38.10 K(-1.6%) | $177.00 K(-29.1%) |
Mar 2015 | - | $38.70 K(-3.5%) | $249.70 K(-15.8%) |
Dec 2014 | - | $40.10 K(-33.3%) | $296.70 K(-11.4%) |
Sep 2014 | - | $60.10 K(-45.8%) | $335.00 K(-4.2%) |
Jun 2014 | $349.70 K(+19.1%) | $110.80 K(+29.3%) | $349.70 K(+5.8%) |
Mar 2014 | - | $85.70 K(+9.3%) | $330.60 K(+4.5%) |
Dec 2013 | - | $78.40 K(+4.8%) | $316.40 K(+3.8%) |
Sep 2013 | - | $74.80 K(-18.4%) | $304.80 K(+3.8%) |
Jun 2013 | $293.60 K(+13.8%) | $91.70 K(+28.3%) | $293.60 K(+7.0%) |
Mar 2013 | - | $71.50 K(+7.0%) | $274.40 K(+1.9%) |
Dec 2012 | - | $66.80 K(+5.0%) | $269.40 K(+1.9%) |
Sep 2012 | - | $63.60 K(-12.3%) | $264.30 K(+2.4%) |
Jun 2012 | $258.00 K | $72.50 K(+9.0%) | $258.00 K(+15.6%) |
Mar 2012 | - | $66.50 K(+7.8%) | $223.20 K(+15.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | - | $61.70 K(+7.7%) | $192.90 K(+16.1%) |
Sep 2011 | - | $57.30 K(+52.0%) | $166.20 K(+16.1%) |
Jun 2011 | $143.30 K(+13.2%) | $37.70 K(+4.1%) | $143.20 K(+2.7%) |
Mar 2011 | - | $36.20 K(+3.4%) | $139.50 K(+3.0%) |
Dec 2010 | - | $35.00 K(+2.0%) | $135.40 K(+1.7%) |
Sep 2010 | - | $34.30 K(+0.9%) | $133.10 K(+5.1%) |
Jun 2010 | $126.60 K(+13.2%) | $34.00 K(+5.9%) | $126.70 K(+2.7%) |
Mar 2010 | - | $32.10 K(-1.8%) | $123.40 K(+4.0%) |
Dec 2009 | - | $32.70 K(+17.2%) | $118.60 K(+4.6%) |
Sep 2009 | - | $27.90 K(-9.1%) | $113.40 K(+1.4%) |
Jun 2009 | $111.80 K(+15.5%) | $30.70 K(+12.5%) | $111.80 K(-113.7%) |
Mar 2009 | - | $27.30 K(-0.7%) | -$816.30 K(+325.6%) |
Dec 2008 | - | $27.50 K(+4.6%) | -$191.80 K(-322.5%) |
Sep 2008 | - | $26.30 K(-102.9%) | $86.20 K(-11.0%) |
Jun 2008 | $96.80 K(-41.8%) | -$897.40 K(-237.7%) | $96.90 K(-90.7%) |
Mar 2008 | - | $651.80 K(+113.4%) | $1.04 M(+111.6%) |
Dec 2007 | - | $305.50 K(+725.7%) | $493.10 K(+151.5%) |
Sep 2007 | - | $37.00 K(-24.6%) | $196.10 K(+18.0%) |
Jun 2007 | $166.20 K(+314.5%) | $49.10 K(-51.6%) | $166.20 K(+30.6%) |
Mar 2007 | - | $101.50 K(+1094.1%) | $127.30 K(+253.6%) |
Dec 2006 | - | $8500.00(+19.7%) | $36.00 K(-4.0%) |
Sep 2006 | - | $7100.00(-30.4%) | $37.50 K(-6.7%) |
Jun 2006 | $40.10 K(-8.2%) | $10.20 K(0.0%) | $40.20 K(-4.3%) |
Mar 2006 | - | $10.20 K(+2.0%) | $42.00 K(-3.7%) |
Dec 2005 | - | $10.00 K(+2.0%) | $43.60 K(0.0%) |
Sep 2005 | - | $9800.00(-18.3%) | $43.60 K(-0.5%) |
Jun 2005 | $43.70 K(+43.8%) | $12.00 K(+1.7%) | $43.80 K(+11.2%) |
Mar 2005 | - | $11.80 K(+18.0%) | $39.40 K(+12.3%) |
Dec 2004 | - | $10.00 K(0.0%) | $35.10 K(+6.7%) |
Sep 2004 | - | $10.00 K(+31.6%) | $32.90 K(+7.9%) |
Jun 2004 | $30.40 K(-21.4%) | $7600.00(+1.3%) | $30.50 K(-3.2%) |
Mar 2004 | - | $7500.00(-3.8%) | $31.50 K(-24.8%) |
Dec 2003 | - | $7800.00(+2.6%) | $41.90 K(+2.4%) |
Sep 2003 | - | $7600.00(-11.6%) | $40.90 K(+5.7%) |
Jun 2003 | $38.70 K(+58.6%) | $8600.00(-52.0%) | $38.70 K(+3.5%) |
Mar 2003 | - | $17.90 K(+163.2%) | $37.40 K(+48.4%) |
Dec 2002 | - | $6800.00(+25.9%) | $25.20 K(+3.3%) |
Sep 2002 | - | $5400.00(-26.0%) | $24.40 K(0.0%) |
Jun 2002 | $24.40 K(+0.8%) | $7300.00(+28.1%) | $24.40 K(+4.3%) |
Mar 2002 | - | $5700.00(-5.0%) | $23.40 K(-5.3%) |
Dec 2001 | - | $6000.00(+11.1%) | $24.70 K(-1.2%) |
Sep 2001 | - | $5400.00(-14.3%) | $25.00 K(+3.7%) |
Jun 2001 | $24.20 K(+29.4%) | $6300.00(-10.0%) | $24.10 K(+35.4%) |
Mar 2001 | - | $7000.00(+11.1%) | $17.80 K(+64.8%) |
Dec 2000 | - | $6300.00(+40.0%) | $10.80 K(+140.0%) |
Sep 2000 | - | $4500.00 | $4500.00 |
Jun 2000 | $18.70 K(+367.5%) | - | - |
Jun 1999 | $4000.00 | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual D&A year-on-year change?
- What is Eloxx Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly D&A year-on-year change?
- What is Eloxx Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM D&A year-on-year change?
What is Eloxx Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ELOX is $695.00 K
What is the all time high annual D&A for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual depreciation & amortization is $960.00 K
What is Eloxx Pharmaceuticals annual D&A year-on-year change?
Over the past year, ELOX annual depreciation & amortization has changed by -$265.00 K (-27.60%)
What is Eloxx Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ELOX is $188.00 K
What is the all time high quarterly D&A for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly depreciation & amortization is $651.80 K
What is Eloxx Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ELOX quarterly depreciation & amortization has changed by -$1000.00 (-0.53%)
What is Eloxx Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ELOX is $737.00 K
What is the all time high TTM D&A for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM depreciation & amortization is $1.04 M
What is Eloxx Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ELOX TTM depreciation & amortization has changed by +$18.00 K (+2.50%)